In a report released yesterday, Kevin Fischbeck from Merrill Lynch reiterated a Buy rating on UnitedHealth (UNH), with a price target of $415.00. The company’s shares closed last Wednesday at $350.84, close to its 52-week high of $367.95.
According to TipRanks.com, Fischbeck is a 4-star analyst with an average return of 10.5% and a 74.3% success rate. Fischbeck covers the Healthcare sector, focusing on stocks such as Universal Health, Tenet Healthcare, and Surgery Partners.
Currently, the analyst consensus on UnitedHealth is a Strong Buy with an average price target of $396.44, a 12.7% upside from current levels. In a report issued on January 5, Truist Financial also maintained a Buy rating on the stock with a $420.00 price target.
See today’s analyst top recommended stocks >>
UnitedHealth’s market cap is currently $332.9B and has a P/E ratio of 20.20. The company has a Price to Book ratio of -25.26.
Based on the recent corporate insider activity of 136 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of UNH in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health services business serving the broad health care marketplace, including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the health care industry. The OptumRx segment provides pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minneapolis, MN.
Read More on UNH: